1. Home
  2. PWP vs CRVS Comparison

PWP vs CRVS Comparison

Compare PWP & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perella Weinberg Partners

PWP

Perella Weinberg Partners

HOLD

Current Price

$13.28

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$9.52

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PWP
CRVS
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
PWP
CRVS
Price
$13.28
$9.52
Analyst Decision
Hold
Strong Buy
Analyst Count
4
8
Target Price
$21.63
★ $33.14
AVG Volume (30 Days)
★ 2.4M
1.2M
Earning Date
10-29-2026
11-03-2026
Dividend Yield
★ 2.12%
N/A
EPS Growth
★ 138.52
48.04
EPS
★ 0.08
N/A
Revenue
N/A
N/A
Revenue This Year
$8.21
N/A
Revenue Next Year
$24.08
N/A
P/E Ratio
$165.38
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.52
$6.39
52 Week High
$25.93
$26.95

Technical Indicators

Market Signals
Indicator
PWP
CRVS
Relative Strength Index (RSI) 35.35 30.01
Support Level $12.52 $6.39
Resistance Level $17.48 $13.73
Average True Range (ATR) 1.01 0.59
MACD -0.20 -0.06
Stochastic Oscillator 12.23 11.37

Price Performance

Historical Comparison
PWP
CRVS

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: